City Residency (India) Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 23-10-2024
- Paid Up Capital ₹ 4.00 M
as on 23-10-2024
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.81 Cr
as on 23-10-2024
- Revenue -2.45%
(FY 2023)
- Profit 76.32%
(FY 2023)
- Ebitda 2.79%
(FY 2023)
- Net Worth 9.25%
(FY 2023)
- Total Assets 33.96%
(FY 2023)
About City Residency (India)
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹11.81 Cr.
Suresh Agarwal, Saurav Agarwal, and Gaurav Agarwal serve as directors at the Company.
- CIN/LLPIN
U45200JH2005PTC011134
- Company No.
011134
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Company Details
- Location
Singhbhum, Jharkhand, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at City Residency (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurav Agarwal  | Director | 27-Jan-2005 | Current |
| Suresh Agarwal | Director | 27-Jan-2005 | Current |
| Gaurav Agarwal | Director | 27-Jan-2005 | Current |
Financial Performance of City Residency (India).
City Residency (India) Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.45% decrease. The company also saw a substantial improvement in profitability, with a 76.32% increase in profit. The company's net worth moved up by a moderate rise of 9.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of City Residency (India)?
In 2023, City Residency (India) had a promoter holding of 60.50% and a public holding of 39.50%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Epic Hotels Private LimitedActive 11 years 9 daysSaurav Agarwal and Gaurav Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Nov 2023 | ₹3.50 Cr | Open |
Others Creation Date: 01 Jun 2023 | ₹4.60 Cr | Open |
Uco Bank Creation Date: 04 Mar 2023 | ₹1.30 Cr | Open |
How Many Employees Work at City Residency (India)?
Unlock and access historical data on people associated with City Residency (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of City Residency (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped City Residency (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
